Woburn, Massachusetts Clinical Trials

A listing of Woburn, Massachusetts clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 81 clinical trials
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

migraine
headache
ly573144
preventive medication
lasmiditan
MedVadis Research Corp
 (7.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +162 other locations
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

This trial studies how well atezolizumab added to the usual radiation therapy works in treating patients with stage I-IIA non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow …

monoclonal antibodies
ct scan
cancer
lung cancer
stage ia2 lung cancer ajcc v8
Lahey Hospital and Medical Center
 (2.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +21 other locations
Pilot Study of the Haymakers for Hope Fitness Program

This research study is assessing the effect of an exercise program on cancer survivors. The exercise program is Haymakers for Hope 16-week exercise program

peripheral neuropathy
cancer
skin cancer
neuropathy
melanoma
Massachusetts General Hospital Cancer Center
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
An Efficacy and Safety Study of Ravulizumab in ALS Participants

The purpose of the study is to assess the efficacy and safety of ravulizumab for the treatment of adult participants with ALS.

ravulizumab
edaravone
vaccination
riluzole
Massachusetts General Hospital
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
ELUCIDATE: Enabling LUng Cancer IDentification Using folATE Receptor Targeting

This is a phase 3, multi-center, single dose, open-label, exploratory study in suspected lung cancer patients scheduled to undergo endoscopic or thoracic surgery per CT/PET/MRI or other imaging based on standard of care. This study aims to assess the efficacy of OTL38 and Near Infrared Imaging (NIR) at identifying pulmonary …

thoracoscopy
folic acid
cancer
lung cancer
wedge excision
Beth Israel Deaconess Medical Center
 (9.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +4 other locations
Mechanism of Action of Transcranial Magnetic Stimulation

This is an observational neuroimaging study assessing the effects of TMS on the brains of patients with unipolar depression.

major depressive disorder
depression
depressive disorder
depressive episode
transcranial magnetic stimulation
Massachusetts General Hospital
 (8.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
ATR Inhibitor BAY 1895344 Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

The purpose of the study is to test how well patients with advanced solid tumors and ovarian cancer respond to treatment with BAY1895344 in combination with niraparib. In addition researchers want to find for patients the optimal dose of BAY1895344 in combination with niraparib, how the drug is tolerated and …

tumor cells
cancer
serum pregnancy test
platelet count
measurable disease
Dana-Farber Cancer Institute
 (9.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
Ibrutinib + Venetoclax in Untreated WM

This study evaluates the safety and efficacy of Ibrutinib combined with Venetoclax (IVEN) in the treatment of adults diagnosed with Waldenstrom's macroglobulinemia (WM) cancer with a specific MYD88 gene mutation. This research study involves an experimental drug combination of targeted therapies. The names of the study drugs involved in this …

igm level
absolute neutrophil count
cancer
serum pregnancy test
bone marrow biopsy
Dana Farber Cancer Institute
 (9.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer

The primary objective of this study is to evaluate the safety and tolerability of H3B-6545 and palbociclib when administered in combination in order to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of this combination in women with advanced or metastatic estrogen receptor-positive (ER+) HER2- …

HER2
epidermal growth factor receptor
her2- breast cancer
stage iv breast cancer
cancer
Massachusetts General Hospital
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
A Study to Evaluate the Safety Pharmacokinetics and Activity of GDC-6036 in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.

kras g12c mutation
metastatic malignant solid tumor
ki-ras
kras
solid tumor
Dana Farber Cancer Institute
 (9.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +7 other locations